Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: EVP of $CYTK Sells 1,042 Shares

Automated

Andrew Callos, the EVP of $CYTK, sold 1,042 shares of the company on 12-08-2025 for an estimated $68,730. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.0% of their shares of this class of stock. Following this trade, they now own 50,660 shares of this class of $CYTK stock.

$CYTK Insider Trading Activity

CYTK Insider Trades

$CYTK insiders have traded $CYTK stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.

Here’s a breakdown of recent trading of $CYTK stock by insiders over the last 6 months:

  • ANDREW CALLOS (EVP, Chief Commercial Officer) has made 0 purchases and 2 sales selling 53,528 shares for an estimated $3,530,182.
  • EDWARD M. MD KAYE has made 0 purchases and 5 sales selling 53,447 shares for an estimated $3,321,199.
  • ROBERT I BLUM (President & CEO) has made 0 purchases and 10 sales selling 50,000 shares for an estimated $2,284,200.
  • FADY IBRAHAM MALIK (EVP Research & Development) has made 0 purchases and 12 sales selling 24,800 shares for an estimated $1,225,808.
  • JOHN T HENDERSON sold 8,750 shares for an estimated $559,125
  • B LYNNE PARSHALL sold 5,000 shares for an estimated $323,650
  • WENDELL WIERENGA sold 4,375 shares for an estimated $256,725
  • ROBERT ARTHUR HARRINGTON has made 0 purchases and 2 sales selling 4,300 shares for an estimated $248,260.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CYTK Hedge Fund Activity

We have seen 229 institutional investors add shares of $CYTK stock to their portfolio, and 173 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CYTK Congressional Stock Trading

Members of Congress have traded $CYTK stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CYTK stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CYTK Analyst Ratings

Wall Street analysts have issued reports on $CYTK in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • B. Riley Securities issued a "Buy" rating on 11/10/2025
  • Barclays issued a "Overweight" rating on 10/06/2025
  • HC Wainwright & Co. issued a "Buy" rating on 09/29/2025
  • JMP Securities issued a "Market Outperform" rating on 09/02/2025
  • Citigroup issued a "Buy" rating on 09/02/2025
  • Stifel issued a "Buy" rating on 09/02/2025
  • Needham issued a "Buy" rating on 09/02/2025

To track analyst ratings and price targets for $CYTK, check out Quiver Quantitative's $CYTK forecast page.

$CYTK Price Targets

Multiple analysts have issued price targets for $CYTK recently. We have seen 10 analysts offer price targets for $CYTK in the last 6 months, with a median target of $83.0.

Here are some recent targets:

  • Leonid Timashev from RBC Capital set a target price of $87.0 on 11/11/2025
  • Mayank Mamtani from B. Riley Securities set a target price of $90.0 on 11/10/2025
  • Gena Wang from Barclays set a target price of $82.0 on 10/06/2025
  • Jason Zemansky from B of A Securities set a target price of $56.0 on 10/02/2025
  • Joseph Pantginis from HC Wainwright & Co. set a target price of $120.0 on 09/29/2025
  • Cory Kasimov from Evercore ISI Group set a target price of $80.0 on 09/03/2025
  • Serge Belanger from Needham set a target price of $72.0 on 09/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles